Nottingham Galway - National University of Ireland, Galway
Nottingham Galway - National University of Ireland, Galway
Nottingham Galway - National University of Ireland, Galway
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Session 3: ENDOCRINE<br />
Chaired by: Pr<strong>of</strong>essor Gordon Wishart, Dr John Kennedy<br />
Panel: Dr Maccon Keane, Pr<strong>of</strong>essor Michael Kerin, Pr<strong>of</strong>essor Mike Dixon,<br />
Dr Paul Donnellan, Dr John Carey<br />
1.30 Optimising the Benefits <strong>of</strong> Endocrine Therapy in Early-Stage Breast Cancer<br />
Pr<strong>of</strong>essor Paul Goss<br />
Pr<strong>of</strong>essor <strong>of</strong> Medicine, Harvard Medical School, MA, USA<br />
2.15 Tailoring Adjuvant Breast Cancer Therapy in Younger Women<br />
Dr Janice Walshe<br />
Consultant Medical Oncologist, Adelaide & Meath Hospitals, Tallaght,<br />
Dublin, <strong>Ireland</strong><br />
2.30 Should Tamoxifen still be considered as a First Line Intervention<br />
Pr<strong>of</strong>essor Carlos Caldas<br />
Pr<strong>of</strong>essor <strong>of</strong> Cancer Medicine, <strong>University</strong> <strong>of</strong> Cambridge, UK<br />
2.45 Discussion<br />
3.30 C<strong>of</strong>fee<br />
Session 4: COST EFFECTIVENESS OF THERAPY<br />
Chaired by: Pr<strong>of</strong>essor Tom Keane, Pr<strong>of</strong>essor Paul Redmond<br />
Panel: Dr Maccon Keane, Pr<strong>of</strong>essor Roger Blamey,<br />
Pr<strong>of</strong>essor Arnie Purushotham, Ms Mairead Lyons<br />
4.00 Cost & Benefit <strong>of</strong> Biologicals<br />
Pr<strong>of</strong>essor Joseph Ragaz<br />
Pr<strong>of</strong>essor <strong>of</strong> Medicine & Oncology, McGill <strong>University</strong>, Montreal, Canada<br />
4.15 Breast Cancer Follow-up: When & By Whom<br />
Dr Maccon Keane<br />
Consultant Oncologist, <strong>Galway</strong> <strong>University</strong> Hospital, <strong>Galway</strong>, <strong>Ireland</strong><br />
4.30 Where are We Going: Insights and Views from Europe<br />
Pr<strong>of</strong>essor Carsten Rose<br />
Pr<strong>of</strong>essor <strong>of</strong> Oncology, Lund <strong>University</strong> Hospital, Lund, Sweden<br />
4.45 Trends in Breast Cancer Treatment Costs<br />
Pr<strong>of</strong>essor Ciaran O’Neill<br />
Pr<strong>of</strong>essor <strong>of</strong> Health Economics, NUI <strong>Galway</strong>, <strong>Galway</strong>, <strong>Ireland</strong><br />
5.00 PROFESSOR FRED GIVEN LECTURE<br />
Introduction: Pr<strong>of</strong>essor Michael Kerin<br />
Speaker:Pr<strong>of</strong>essor John Crown<br />
Topic: Future in Adjuvant Breast Cancer Treatment<br />
7.30 RECEPTION AND GALA DINNER<br />
GALWAY BAY HOTEL, SALTHILL<br />
7